The multidrug resistance transporters CgTpo1_1 and CgTpo1_2 play a role in virulence and biofilm formation in the human pathogen Candida glabrata: CgTpo1s play a role inC. glabratavirulence
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The mechanisms of persistence and virulence associated with Candida glabrata infections are poorly understood, limiting the ability to fight this fungal pathogen. In this study, the multidrug resistance transporters CgTpo1_1 and CgTpo1_2 are shown to play a role in C. glabrata virulence. The survival of the infection model Galleria mellonella, infected with C. glabrata, was found to increase upon the deletion of either CgTPO1_1 or CgTPO1_2. The underlying mechanisms were further explored. In the case of CgTpo1_1, this phenotype was found to be consistent with the observation that it confers resistance to antimicrobial peptides (AMP), such as the human AMP histatin-5. The deletion of CgTPO1_2, on the other hand, was found to limit the survival of C. glabrata cells when exposed to phagocytosis and impair biofilm formation. Interestingly, CgTPO1_2 expression was found to be up-regulated during biofilm formation, but and its deletion leads to a decreased expression of adhesin-encoding genes during biofilm formation, which is consistent with a role in biofilm formation. CgTPO1_2 expression was further seen to decrease plasma membrane potential and affect ergosterol and fatty acid content. Altogether, CgTpo1_1 and CgTpo1_2 appear to play an important role in the virulence of C. glabrata infections, being at the cross-road between multidrug resistance and pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Noble, S. M., French, S., Kohn, L. A., Chen, V., & Johnson, A. D. (2010) · Nature Genetics · doi:10.1038/ng.605 · Cited by 678
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647 · cited 2×
“C. glabrata has the capacity to adhere to other cells, such as phagocytic or epithelial cells, but also to abiotic surfaces, such as catheters, prosthesis or other medical artificial material implanted in the human body (Cowen et al., 2014), forming biofilms (Roetzer, Gabaldón, & Schüller, 2011).”
BackgroundEpidemiology and risk factors for invasive candidiasis
Yapar, N. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s40160 · Cited by 610 · cited 1×
“Infections caused by this pathogenic yeast have increased worldwide (Rodrigues, Silva, & Henriques, 2014; Yapar, 2014).”
BackgroundFlocculation, adhesion and biofilm formation in yeasts
Verstrepen, K. J., & Klis, F. M. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05072.x · Cited by 589 · cited 2×
“The shortage of nutrients is one of the triggers leading to cell adherence and biofilm formation (Verstrepen & Klis, 2006; Fisher, Kavanagh, Sobel, Kauffman, & Newman, 2011; Riera et al., 2012).”
BackgroundPfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101510 · Cited by 396 · cited 2×
“This observation is mostly likely due to the relatively high prevalence of antifungal drug resistance among C. glabrata clinical isolates (Tscherner et al., 2011; Pfaller et al., 2014).”
BackgroundResultAdhesins in human fungal pathogens: glue with plenty of stick.
de Groot, P. W. J., Bader, O., de Boer, A. D., Weig, M., & Chauhan, N. (2013) · Eukaryotic Cell · doi:10.1128/ec.00364-12 · Cited by 319
Novel Entries in a Fungal Biofilm Matrix Encyclopedia
Zarnowski, R., Westler, W. M., Lacmbouh, G. A., Marita, J. M., Bothe, J. R., Bernhardt, J., Lounes-Hadj Sahraoui, A., Fontaine, J., Sanchez, H., Hatfield, R. D., et al. (2014) · mBio · doi:10.1128/mbio.01333-14 · Cited by 315
Candida glabrata: A review of its features and resistance
Rodrigues, C. F., Silva, S., & Henriques, M. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-2009-3 · Cited by 268
Seider, K., Brunke, S., Schild, L., Jablonowski, N., Wilson, D., Majer, O., Barz, D., Haas, A., Kuchler, K., Schaller, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003730 · Cited by 220 · cited 2×
“glabrata is able to survive and replicate for a very prolonged time (Seider et al., 2011), the use of Galleria mellonella larvae may be considered an interesting model of what happens inside the human host.”
BackgroundRoetzer, A., Gabaldón, T., & Schüller, C. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02102.x · Cited by 154
Chen, Y., Montedonico, A. E., Kauffman, S., Dunlap, J. R., Menn, F., & Reynolds, T. B. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.07018.x · Cited by 144 · cited 2×
“Finally, taking into account the importance of lipid composition in biofilm development and virulence in Candida albicans (Chen et al., 2010; Noble, French, Kohn, Chen, & Alexander, 2010; Shah et al., 2014), an analysis of ergosterol content and of the fatty acid profile of the wild type and derived mutant Δcgtpo1_2 w…”
BackgroundAutophagy supports Candida glabrata survival during phagocytosis
Roetzer, A., Gratz, N., Kovarik, P., & Schüller, C. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01391.x · Cited by 142
Candida albicans biofilms: building a heterogeneous, drug-tolerant environment
Bonhomme, J., & d’Enfert, C. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.03.007 · Cited by 120 · cited 2×
“…of ergosterol in C. glabrata cells was further assessed, given its importance in biofilm formation, either as part of the cell membrane composition (Bonhomme & D'Enfert, 2013; Shah et al., 2014) or, as recently demonstrated, as part of the extracellular matrix of the biofilm of Candida albicans…”
BackgroundNevitt, T., & Thiele, D. J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001322 · Cited by 95 · cited 1×
“Candida glabrata is the second or third most common cause of invasive candidiasis (Tscherner, Schwarzmüller, & Kuchler, 2011), with an estimated death rate of 40–50% (Nevitt & Thiele, 2011).”
BackgroundCosta, C., Henriques, A., Pires, C., Nunes, J., Ohno, M., Chibana, H., Sá-Correia, I., & Teixeira, M. C. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00170 · Cited by 45
Self-citationNew regulators of biofilm development in Candida glabrata
Riera, M., Mogensen, E., d’Enfert, C., & Janbon, G. (2012) · Research in Microbiology · doi:10.1016/j.resmic.2012.02.005 · Cited by 43
Costa, C., Ribeiro, J., Miranda, I. M., Silva-Dias, A., Cavalheiro, M., Costa-de-Oliveira, S., Rodrigues, A. G., & Teixeira, M. C. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00526 · Cited by 43
Self-citation
Cited by
Candida Biofilms: Threats, Challenges, and Promising Strategies
Cavalheiro, M., & Teixeira, M. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00028 · Cited by 690
Self-citationTimmermans, B., De Las Peñas, A., Castaño, I., & Van Dijck, P. (2018) · Journal of Fungi · doi:10.3390/jof4020060 · Cited by 109
Deletion of ADA2 Increases Antifungal Drug Susceptibility and Virulence in Candida glabrata
Yu, S.-J., Chang, Y.-L., & Chen, Y.-L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01924-17 · Cited by 43
“glabrata mutants, such as the tpo1_1 and tpo1_2 mutants, which have a reduced agar invasion ability compared with that of the wild type, show reduced virulence in a Galleria mellonella infection model (43).”
BackgroundCavalheiro, M., Costa, C., Silva-Dias, A., Miranda, I. M., Wang, C., Pais, P., Pinto, S. N., Mil-Homens, D., Sato-Okamoto, M., Takahashi-Nakaguchi, A., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00995-18 · Cited by 42
Self-citationZhao, J.-T., Chen, K.-Z., Liu, J.-Y., Li, W.-H., Wang, Y.-Z., Wang, L.-L., & Xiang, M.-J. (2022) · Brazilian Journal of Microbiology · doi:10.1007/s42770-022-00703-7 · Cited by 9
Metadata
- Authors
- Santos, R., Costa, C., Mil-Homens, D., Romão, D., de Carvalho, C. C. C. R., Pais, P., Mira, N. P., Fialho, A. M., & Teixeira, M. C.
- Venue
- Cellular Microbiology
- Publisher
- Wiley
- Published
- 2017-01-03
- Volume
- 19
- Issue
- 5
- Pages
- e12686
- ISSN
- 1462-5814 (ISSN-L)
- OpenAlex
- W2545646403
- Cited by
- 33
- References
- 17
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.